About us Our Approach Services Industries Contacts
About TCI
Our Approach
Services
Industries
  - Automotive and Transportation
  - Chemicals and Polymers
  - Communications and Electronics
  - Construction
  - Fabricated materials and products
  - Food and Ingredients
  - Metals and Minerals
  - Packaging
  - Pharmaceuticals and Healthcare
Contacts
 
Pharmaceuticals and healthcare

Pharmaceuticals and Healthcare is one of TCI's larger practice areas, and one in which we work for manufacturers of pharmaceuticals, medical devices and equipment, as well as for the service providers themselves. Although the majority of projects are in Europe and the USA, we also have experience of working in global markets.

The services we offer to pharmaceutical manufacturers include competitive intelligence on new product developments, assessment of product landscapes, benchmarking, market opportunity analysis and due diligence assessment of potential licensing partners or acquisition candidates.

We have experience of a broad range of therapeutic and product areas, including:

  • Analgesics
  • Anti-inflammatories
  • Anxiety and Depression
  • Cardiovascular
  • Central Nervous System
  • Dermatology
  • Diabetes
  • Gastrointestinal
  • Infectious Diseases
  • Inflammatory Diseases
  • Musculoskeletal
  • Obesity
  • Oncology
  • Vision Care
  • Woundcare

Please contact us to discuss your specific needs and our relevant product, technology and industry expertise.  

Case Study

Issue:
A pharmaceutical manufacturer was considering the opportunity to license-in a nephrology product that addresses one of the side effects of renal dialysis and needed to develop an understanding of the potential opportunity in a series of Asian markets

Approach:
Since the client needed the information across 10 markets in a rapid period of time and with a limited budget, TCI decided to concentrate its efforts on a series of face to face interviews with doctors and key opinion leaders at a major international nephrology conference. This was expanded where necessary with subsequent telephone interviews in specific target countries

Outcome:
TCI was able to characterise the market in each country through an understanding of the disease incidence and prevalence and the number of specialist physicians and institutions, as well as assessing the likely market price that would be attainable. Specific recommendations were also provided on potential local partners to address the client’s limited distribution capabilities in the region